The COGCOV Study in ICU Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-07

Study Completion Date

2021-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute Respiratory Distress syndrome (ARDS) is a pulmonary systematic inflammatory response, leading to acute respiratory failure with hypoxia and/or hypercarbia. COVID-19 evokes a viral pneumonia, which may result in ARDS as well. It is not yet clear if COVID-19 disease behaves like the typical ARDS. Corona virus causes primarily deep hypoxia. Hypoxia, on its own, can lead to long term cognitive impairment. However, critical illness also affects long-term neurocognitive functioning. The investigators will be researching the possibility of long-term cognitive impairment in COVID-19 ICU patients, in comparison with reference values of a healthy population as well as the values measured in critically ill patients, admitted not only for respiratory reasons.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.

NCT05019300

Covid19 Neurocognitive Dysfunction

UNKNOWN

Digital Cognition Study During Long-COVID

NCT06391970

COVID-19, Long Haul

RECRUITING NA

Long-Covid: Treatment of Cognitive Difficulties

NCT05167266

COVID-19 Cognitive Dysfunction

COMPLETED NA

Pilot Study of Early Cognitive Training in the Intensive Care Unit

NCT03284437

Intensive Care Units, Delirium, Cognitive Dysfunction

WITHDRAWN NA

Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19

NCT05582603

Post-Acute COVID-19 Post Acute COVID-19 Syndrome Cognitive Dysfunction +1 more

UNKNOWN PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will conduct a single centre, prospective cohort study. COVID-19 patients from the Ziekenhuis Oost-Limburg cohort will be contacted by phone 6 months after admission at the ICU. Patients will be asked to participate in a study surrounding long term symptoms of COVID-19. When consent is given by the patiënt, the experimenter will conduct a short questionnaire over the phone with the patient or relative that is present at the time of the call. If the participant is fluent in Dutch, the experimenter will ask permission to visit their home to conduct more testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All patients enrolled in the study will be contacted to answer additional questions regarding cognitive impairment

Primary Study Purpose

OTHER

Blinding Strategy

NONE

masking is not applicable for this study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19 patients

Neurocognitive impairment in COVID-19 patients

Group Type OTHER

Neurocognitive assessment

Intervention Type BEHAVIORAL

6 months after admission to the intensive care unit of Ziekenhuis Oost-Limburg, the patients will be tested on cognitive impairment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurocognitive assessment

6 months after admission to the intensive care unit of Ziekenhuis Oost-Limburg, the patients will be tested on cognitive impairment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to the intensive care unit of Ziekenhuis Oost-Limburg
* Being hospitalized between March 2020 and May 2020, and therefore being admitted 6 months prior to the study
* The reason of hospitalization was COVID-19 disease